NovoCure (NVCR) EBITDA Margin (2014 - 2026)
NovoCure (NVCR) reported EBITDA Margin of -3.41% for Q2 2026, up 19.31 percentage points from -22.72% a year earlier and up 32.96 percentage points from the prior quarter.
Powered by 
Analysis
NovoCure (NVCR) EBITDA Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, NovoCure's EBITDA Margin came in at -19.75%, up 5.71 percentage points year-over-year; for FY2025, it was -21.23%, up 5.08 percentage points from FY2024.
- EBITDA Margin has a five-year change of -29.23 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -26.31% in FY2024 (+17.25 pp), -43.57% in FY2023 (-28.90 pp), -14.67% in FY2022 (-8.30 pp) and -6.37% in FY2021 (-14.37 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin since Q1 2022.
- Year over year, EBITDA Margin gained in four of the last eight quarters, with an average year-over-year change of +6.08 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q2 2024 (a gain of 27.12 percentage points); the low point was Q1 2023 (a drop of 48.39 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -36.37% (Q1 2026), -20.75% (Q4 2025) and -19.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 31.93% |
| 10 | NovoCure | 1.81 Bn | -546.26 Mn | 142.48 Mn | -4.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.82% |
| Mar 31, 2026 | -37.87% |
| Dec 31, 2025 | -22.90% |
| Sep 30, 2025 | -23.18% |
| Jun 30, 2025 | -26.79% |
| Mar 31, 2025 | -26.58% |
| Dec 31, 2024 | -41.47% |
| Sep 30, 2024 | -23.45% |
| Jun 30, 2024 | -24.99% |
| Mar 31, 2024 | -31.83% |
| Dec 31, 2023 | -42.05% |
| Sep 30, 2023 | -48.80% |
| Jun 30, 2023 | -51.58% |
| Mar 31, 2023 | -50.40% |
| Dec 31, 2022 | -33.92% |
| Sep 30, 2022 | -16.58% |
| Jun 30, 2022 | -12.53% |
| Mar 31, 2022 | 1.81% |
| Dec 31, 2021 | -14.97% |
| Sep 30, 2021 | -3.77% |
API Access
NovoCure EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NVCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NVCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NVCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();